Citadel Advisors’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
DTC
Citadel Advisors's WGS Position: Q2 2026 in Review
Citadel Advisors increased its GeneDx Holdings (WGS) stake by 34% in Q2 2026, buying an estimated $12.4M and bringing the position to 865,462 shares worth $59.4M. The position accounts for 0.01% of the portfolio, ranked #1406.
Citadel Advisors first reported a position in WGS in Q1 2021 and has held it in 20 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- Citadel Advisors held 865,462 shares of GeneDx Holdings worth $59.4M as of Q2 2026.
- Citadel Advisors bought 218,061 GeneDx Holdings shares in Q2 2026, an estimated $12.4M.
- GeneDx Holdings made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1406 holding.
- Citadel Advisors first reported a position in GeneDx Holdings in Q1 2021 and has held it in 20 quarters since.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.